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Abstract
Multiple genome-wide and targeted association studies reveal a significant association of variants in the CHRNA5-CHRNA3-
CHRNB4 (CHRNA5/A3/B4) gene cluster on chromosome 15 with nicotine dependence. The subjects examined in most of these
studies had a European origin. However, considering the distinct linkage disequilibrium patterns in European and other ethnic
populations, it would be of tremendous interest to determine whether such associations could be replicated in populations of
other ethnicities, such as Asians. In this study, we performed comprehensive association and interaction analyses for 32 single-
nucleotide polymorphisms (SNPs) in CHRNA5/A3/B4 with smoking initiation (SI), smoking quantity (SQ), and smoking cessation
(SC) in a Korean sample (N=8,842). We found nominally significant associations of 7 SNPs with at least one smoking-related
phenotype in the total sample (SI: P=0.015,0.023; SQ: P=0.008,0.028; SC: P=0.018,0.047) and the male sample (SI:
P=0.001,0.023; SQ: P=0.001,0.046; SC: P=0.01). A spectrum of haplotypes formed by three consecutive SNPs located
between rs16969948 in CHRNA5 and rs6495316 in the intergenic region downstream from the 59 end of CHRNB4 was
associated with these three smoking-related phenotypes in both the total and the male sample. Notably, associations of these
variants and haplotypes with SC appear to be much weaker than those with SI and SQ. In addition, we performed an
interaction analysis of SNPs within the cluster using the generalized multifactor dimensionality reduction method and found a
significant interaction of SNPs rs7163730 in LOC123688, rs6495308 in CHRNA3, and rs7166158, rs8043123, and rs11072793 in
the intergenic region downstream from the 59 end of CHRNB4 to be influencing SI in the male sample. Considering that fewer
than 5% of the female participants were smokers, we did not perform any analysis on female subjects specifically. Together,
our detected associations of variants in the CHRNA5/A3/B4 cluster with SI, SQ, and SC in the Korean smoker samples provide
strong evidence for the contribution of this cluster to the etiology of SI, ND, and SC in this Asian population.
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Introduction
There are about 1.3 billion smokers worldwide, and the
mortality burden from tobacco use has been estimated to exceed
6 million annually [1]. In Korea, male smoking prevalence is
among the highest in the world [2]. In 2000, the prevalence was
estimated to be 68% among men and 3% among women [2]. The
number of deaths attributable to smoking-related diseases in
Korea is about 35,000 each year, and the economic loss from
premature death from smoking-related diseases exceeded 3 trillion
won (approximately US $2.5 billion) in the year 2000 [3].
Nicotine is the psychoactive substance in tobacco that causes
addiction. Many of those who want to quit smoking do not seek
treatment but are unable to quit on their own [4]. Evidence for
moderate heritabilities of smoking initiation (SI), nicotine dependence
(ND), and smoking cessation (SC) has led to intensive efforts to identify
susceptibility loci for these complex behavioral phenotypes [5,6,7,8].
The psychopharmacologic effects of nicotine are mediated primarily
by functionally diverse neuronal nicotinic acetylcholine receptors
(nAChRs), a family of ligand-gated ion channels widely distributed in
the brain [9,10,11]. Because of their unique functions, genes encoding
various nAChR subunits have been proposed as plausible candidates
for genetic studies of ND. Several subunit genes have been investigated
for associations with ND as well as other smoking-related behaviors in
human subjects (for reviews, see [12,13]).
Initially, Saccone et al. [14] reported associations of multiple
single nucleotide polymorphisms (SNPs) in the CHRNA5/A3/B4
gene cluster with ND, with the smallest P value of 0.00064 for
rs16969968 (D398N) in exon 5 of CHRNA5. However, the
significance of these results did not survive correction for multiple
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12183testing. Shortly after the initial publication, rs1051730 (Y215Y) in
exon 5 of CHRNA3 was reported to be significantly associated at a
genome-wide level with smoking quantity (SQ) [15] and lung
cancer (LC) [15,16,17]. Several other genome-wide and candidate
gene-based association studies provided further evidence for the
association of variants of the CHRNA5/A3/B4 cluster with various
nicotine-related behaviors [14,18,19,20,21,22,23,24,25]. In con-
trast, other studies have failed to reveal a significant association of
this gene cluster with ND or other smoking-related phenotypes
[26,27].
Considering that (1) the participants in most of these studies were
primarily European Americans or of European origin, with the
exception oftwostudies onAfricanAmericans[18,28], and(2)there
aredistinctdifferencesinlinkagedisequilibrium(LD)patternsacross
different ethnic populations [12], it is of tremendous interest to
determine whether variants in this gene cluster play any role in the
etiologies of smoking behavioral phenotypes in other ethnic groups.
Thus, the major objective of this study was to test for such genetic
effects in a large population-based Korean sample.
Results
Description of KARE sample in its relation to smoking
behaviors
Of the 8,842 subjects, 4,205 were recruited from Ansung and 4,637
from Ansan, Korea. Their average ages were 55.668.74 (standard
deviation; SD) and 49.167.86 years, respectively. Although 52.7% of
the participants (N=4,659) were female, only 4.93% of these were
considered either former (1.34%), light (1.29%), or habitual (2.30%)
smokers. In contrast, 80.62% of the male subjects were smokers, with
31.05% being former smokers, 4.78% light smokers, and 44.79%
habitual smokers. For those habitual smokers, the average number of
cigarettes smoked per day (CPD) was 19.5168.74 for male and
11.9367.28 for female smokers. A detailed description of the
characteristics of all subjects is presented in Table 1.
Individual SNP-based association analysis
Among the 36 SNPs genotyped for the 15q24-15q25.1 region
in CHRNA5/A3/B4, only 32 had a minor allele frequency (MAF)
of .0.01. Considering the differences in LD patterns of the region
across multiple ethnic samples and to have a better understanding
of the LD landscape within this region in the Korean vs. the other
ethnic populations, Table S1 provides a detailed list of all
genotyped SNPs for the total and male samples. However, only
those 32 SNPs with MAFs .0.01 were used in the association
analyses for the three smoking-related phenotypes.
Associations of individual SNPs with the three phenotypes were
determined with the PLINK program [29], and the results are shown
in Table 2. Altogether, we found 7 SNPs that had nominally
significant associations with at leastone smoking-related phenotype in
e i t h e rt h et o t a lo rt h em a l es a m p l e .I nt h et o t a ls a m p l e ,w ef o u n dt h a t
the A allele of rs951266 in CHRNA5 was nominally significantly
associated with SI (P=0.023; odds ratio [OR] =1.32; 95%
confidence interval [CI]:=1.04, 1.67) and SQ (P=0.008;
OR=1.48; 95% CI: 1.11, 1.98), and the G allele of rs11072768 in
CHRNB4 was nominally significantly associated with SI (P=0.015;
OR=1.14; 95% CI: 1.03, 1.27), SQ (P=0.028; OR=1.17; 95% CI:
1.02, 1.34), and SC (P=0.018; OR=1.16; 95% CI: 1.03, 1.31).
Furthermore, the associations of SNPs rs8043123 (C), rs4887077 (T),
and rs11638372 (T) with SQ and the association of rs2869550 (C)
with SC reached nominal significance.
In the male sample, the G allele of rs11072768 in CHRNB4 was
nominally significantly associated with SI (P=0.001; OR=1.22;
95% CI: 1.08, 1.37), SQ (P=0.016; OR=1.16; 95% CI: 1.03,
Table 1. Demographic characteristics of study subjects.
Category Sub-Category Ansung Ansan Total
Sample Size (N) 4,205 4,637 8,842
Male/female (%) 1,809 (43)/
2,396 (57)
2,374 (51.2)/
2,263 (48.8)
4,183 (47.3)/
4,659 (52.7)
Mean age (years)6SD 55.6068.74 49.0867.86 52.2268.92
Smoking status (Total sample) Never smoked 2,492 2,651 5,143
Mean CPD for ‘‘Former Smokers’’
6 SD (N)
18.88611.88
(512)
19.11612.14
(842)
19.02612.04
(1,354)
Number of occasional smokers 155 103 258
Mean CPD for ‘‘Habitual Smokers’’ 6 SD (N) 19.3368.41
(950)
18.9169.20
(1,020)
19.1168.83
(1,970)
Smoking status (Male sample) Never smoked 306 501 807
Mean CPD for ‘‘Former Smokers’’ 6 SD (N) 19.60611.76
(481)
19.52612.06
(812)
19.55611.94
(1,293)
Number of occasional smokers 118 81 199
Mean CPD for ‘‘Habitual Smokers’’ 6 SD (N) 19.8168.20
(887)
19.2369.19
(978)
19.5168.74
(1,865)
Smoking status (Female sample) Never smoked 2,186 2,150 4,336
Mean CPD for ‘‘Former Smokers’’ 6 SD (N) 6.3564.96
(31)
7.0767.53
(30)
6.7266.35
(61)
Number of occasional smokers 37 22 59
Mean CPD for ‘‘Habitual Smokers’’ 6 SD (N) 12.4268.30
(63)
11.1865.34
(42)
11.9367.28
(105)
doi:10.1371/journal.pone.0012183.t001
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rs951266 (A) in CHRNA5 and rs6495308 (T) in CHRNA3 were
nominally significantly associated with SI and SQ, respectively. In
addition, we found that SNPs rs4887077 (T) and rs11638372 (T)
in the intergenic region downstream from the 59 end of CHRNB4
were nominally significantly associated with SQ. Of these
associations, only that of rs951266 in CHRNA5 with SQ and
rs11072768 in CHRNA4 with SI remained significant after
correction for multiple testing.
We did not perform the association analysis on the female
sample because fewer than 5% of these subjects smoked, such that
the sample was too small to derive any meaningful conclusions.
Haplotype block structure and LD analysis
The pair-wise D’ values of 32 SNPs within CHRNA5/A3/B4
were determined using the Haploview program [30]. On the basis
of the block definition proposed by Gabriel et al. [31], we found
three discernible haplotype blocks within the cluster in the total
sample (Figure 1). The first block, with a size of about 10 kb,
contains four SNPs between rs169669920 and rs7163730; the
second block, with a size of 46 kb, contains 12 SNPs; the third
block, with a size of 23 kb, contains only two SNPs — rs11072793
and rs11072794. Considering that (1) no haplotype block was
detected within a genomic region of about 108 kb between
rs481134 and rs6495316, and (2) the three discernible haplotype
blocks did not correspond to the defined genes within this region,
we decided to perform haplotype-based association analysis using
a sliding window approach with a window size of three consecutive
SNPs [32], as described in the following section.
Haplotype-based association analysis
Using the Haplo.stats R statistics package [33], we performed
haplotype-based association analysis for the three smoking-related
phenotypes in both the total and male samples (Tables 3 and 4). In
the total sample, we found five major haplotypes between SNPs
rs16969948 in CHRNA5 and rs6495316 in the intergenic region
downstream from the 59 end of CHRNB4 that were significantly
associated with SI under the additive or dominant model. Of these
haplotypes, two were positively, and the remaining three were
negatively, associated with SI, with P values ranging from 0.013
for the haplotype ACT, formed by rs950776-rs11072768-
rs7166158, to 0.047, for the haplotype TCC, formed by
rs16969948-rs481134-rs951266.
For SQ, we found seven major haplotypes between SNPs
rs16969948 in CHRNA5 and rs6495316 in the intergenic region
downstream from the 59 end of CHRNB4 that showed significant
associations. Of these haplotypes, two were positively, and the
remaining five were negatively, associated with SI, with a P value
ranging from 0.014 for the haplotype CCT, formed by rs481134-
rs951266-rs514743, to 0.044 for the haplotype GGA, formed by
rs4887077-rs11638372-rs6495316. Although we performed iden-
tical association analyses for SC, we found no significant
haplotypes in the total sample. By comparing significant
haplotypes with SI and SQ, we found four haplotypes, GAA
(rs6495308-rs950776-rs11072768), ACT (rs950776-rs11072768-
rs7166158), CTC (rs11072768-rs7166158-rs8043123), and GGA
(rs4887077-rs11638372-rs6495316), to be significantly associated
with both phenotypes under identical genetic models, indicating
that they contribute to the etiologies of these two behaviors, likely
through a common uncharacterized mechanism.
Similarly, we performed haplotype-based association analysis for
the male sample (Table 4). Altogether, we found that ten haplotypes
between SNPs rs16969948 in CHRNA5 and rs11638372 in the
intergenic region downstream from the 59 end of CHRNB4 showed
significant associations with at least one smoking-related phenotype.
By comparing the haplotype-based association results of the total and
male samples, we found six that were comparable in the two samples,
except that the association signals appear to be much stronger in the
male sample. For example, the P values of associations with SI, SQ,
Table 2. P values for SNPs significantly associated with at least one smoking-related phenotype and their corresponding odds
ratios and 95% confidence intervals under the additive and dominant model.
Total Sample Male Sample
SI SQ SC SI SQ SC
Gene dbSNP ID
Risk
Allele P
OR
(95% CI) P
OR
(95% CI) P
OR
(95% CI) P
OR
(95% CI) P
OR
(95% CI) P
OR
(95%CI)
CHRNA5 rs951266 A 0.023
a 1.32
(1.04, 1.67)
0.008
a 1.48
(1.11, 1.98)
0.405
a 1.14
(0.84, 1.55)
0.006
a 1.46
(1.11, 1.91)
0.001
a 1.71
(1.24, 2.34)
0.351
a 1.16
(0.85, 1.60)
CHRNA3 rs6495308 T 0.150
a 1.06
(0.98, 1.16)
0. 110
a 1.09
(0.98, 1.21)
0.287
a 1.06
(0.95, 1.19)
0.023
a 1.11
(1.02, 1.22)
0.046
a 1.12
(1.00, 1.26)
0.230
a 1.07
(0.96, 1.20)
CHRNB4 rs11072768 G 0.015
d 1.14
(1.03, 1.27)
0.028
d 1.17
(1.02, 1.34)
0.018
a 1.16
(1.03, 1.31)
0.001
d 1.22
(1.08, 1.37)
0.016
a 1.16
(1.03, 1.31)
0.010
a 1.18
(1.04, 1.34)
Intergenic
region
rs8043123 C 0.329
d 0.93
(0.80, 1.08)
0.022
d 0.84
(0.73, 0.98)
0. 218
a 0.94
(0.85, 1.04)
0.422
a 1.05
(0.94, 1.17)
0.092
d 0.88
(0.75, 1.02)
0. 256
a 0.94
(0.85, 1.04)
Intergenic
region
rs4887077 T 0.079
a 1.39
(0.96, 2.01)
0.022
a 1.51
(1.06, 2.14)
0.575
d 0.90
(0.63, 1.30)
0.063
a 1.58
(0.98, 2.55)
0.008
a 1.68
(1.15, 2.47)
0.552
d 0.89
(0.61, 1.30)
Intergenic
region
rs2869550 C 0.554
d 1.03
(0.92, 1.16)
0.659
d 1.03
(0.89, 1.19)
0.047
d 1.16
(1.00, 1.35)
0.538
d 1.04
(0.92, 1.18)
0.819
d 1.02
(0.87, 1.19)
0.079
d 1.15
(0.98, 1.34)
Intergenic
region
rs11638372 T 0.102
a 1.36
(0.94, 1.96)
0.027
a 1.48
(1.05, 2.09)
0.645
d 0.92
(0.64, 1.32)
0.081
a 1.52
(0.95, 2.43)
0.010
a 1.65
(1.13, 2.41)
0.623
d 0.91
(0.63, 1.32)
(1) OR = odds ratio; CI = confidence interval; SI = smoking initiation; SC = smoking cessation, SQ = smoking quantity. (2) Significant associations at the 0.05 level
before Bonferroni correction for multiple testing are given in bold and those significant after Bonferroni correction for multiple testing are in bold and underlined
(corrected P value at a 0.05 significance level is 0.0016 (=0.05/32). (3) Superscripts indicate the genetic model used in the analysis: a = additive and d = dominant. (4)
For each sample, age, sex, and area were used as covariates.
doi:10.1371/journal.pone.0012183.t002
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rs7166158 under the dominant model, are, respectively, 0.001, 0.014,
and 0.019 in the male sample and 0.013, 0.033, and 0.06 in the total
sample. Very interestingly, we found that haplotypes ACT, formed by
rs950776-rs11072768-rs7166158, and CTC, formed by rs11072768-
rs7166158-rs8043123, were nominally significantly associated with all
three smoking-related phenotypes in the male sample, suggesting that
this region is a good target for further sequencing analysis with the
hope of identifying variants that contribute to our observed association
of the cluster with these smoking-related phenotypes.
Interaction analysis of CHRNA5/A3/B4 with SI, SQ, and SC
To further determine a genetic contribution of the CHRNA5/
A3/B4 cluster to the three smoking-related phenotypes, we
Table 3. Statistics estimates and P values for major haplotypes showing significant associations at the 0.05 level with at least one
smoking-related phenotype under the additive and dominant models in the total sample.
SNP Number SNP combinations
Haplo-
type Freq SI SQ SC
Esti-mate P
Global
P value Esti-mate P
Global
P
Esti-
mate P Global P
18-19-20 rs16969948-rs481134-rs951266 TCC 0.76 20.304
d 0.047
d 0.108
d 20.248
d 0.087
d 0.209
d 20.013
d 0.928
d 0.261
d
19-20-21 rs481134-rs951266-rs514743 CCT 0.81 20.326
d 0.092
d 0.233
d 20.147
a
20.457
d
0.017
a
0.014
d
0.006
a
0.050
d
20.105
d 0.579
d 0.299
d
21-22-23 rs514743-rs6495308-rs950776 TGA 0.73 20.081
a 0.056
a 0.263
a 20.111
a 0.038
a 0.134
a 20.072
a 0.198
a 0.324
a
22-23-24 rs6495308-rs950776-rs11072768 GAA 0.70 20.088
a 0.031
a 0.141
a 20.116
a 0.025
a 0.131
a 20.097
a 0.073
a 0.279
a
23-24-25 rs950776-rs11072768-rs7166158 ACT 0.12 0.163
d 0.013
d 0.144
d 0.176
d 0.033
d 0.200
d 0.165
d 0.06
d 0.244
d
24-25-26 rs11072768-rs7166158-rs8043123 CTC 0.15 0.118
a 0.034
a 0.103
a 0.145
a 0.038
a 0.229
a 0.136
a 0.068
a 0.014
a
26-27-29 rs8043123-rs4887077-rs11638372 TGG 0.45 20.051
d 0.375
d 0.327
d 20.172
d 0.020
d 0.009
d 20.038
d 0.626
d 0.344
d
27-29-30 rs4887077-rs11638372-rs6495316 GGA 0.88 20.634
d 0.028
d 0.073
d 20.531
d 0.044
d 0.125
d 0.023
d 0.931
d 0.869
d
(1) SI = smoking initiation; SQ = smoking quantity; SC = smoking cessation; (2) Significant associations at the 0.05 level before Bonferroni correction for multiple
testing are given in bold; (3) Superscripts indicate the genetic model used: a = additive; d = dominant; (4) For each sample, age, sex, and geographic area were used as
covariates.
doi:10.1371/journal.pone.0012183.t003
Figure 1. Haploview-generated LD patterns for 32 SNPs within the CHRNA5/A3/B4 cluster in the Korean total sample. Pair-wise LD
between all SNPs was evaluated using the Haploview program [30] with the option of determining haplotype blocks according to the criteria defined
by Gabriel et al. [31]. The number in each box represents the D’ value for each SNP pair.
doi:10.1371/journal.pone.0012183.g001
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samples as we did previously for nAChR genes alpha 4 (CHRNA4)
and beta 2 (CHRNB2) [34] and GABA-B receptor subunits 1
(GABAB1) and 2 (GABAB2) [35]. By using the generalized
multifactor dimensionality reduction (GMDR) approach [36], we
performed the interaction analysis for all possible combinations of
two to six SNPs within CHRNA5/A3/B4 for SI and SC in both the
total and the male sample. Among these gene-gene interaction
analyses, a significant result emerged only in the male sample for
SI, with the best interaction model consisting of SNPs rs7163730
in LOC123688, rs6495308 in CHRNA3 and rs7166158, rs8043123,
and rs11072793 from the downstream region of CHRNB4; the
corresponding P value was 0.011 (Table 5). Because of the
limitation of the current GMDR version, which cannot handle
ordinal phenotypes such as SQ, we could not carry out gene-gene
interaction analysis on this particular phenotype in our samples.
However, we did perform interaction analysis on SQ by
employing a cumulative logit model, which revealed no significant
interactions of SNPs located in this genomic region in affecting
SQ.
Discussion
In the current study, we examined genetic associations and
epistatic variants in CHRNA5/A3/B4 with SI, SQ, and SC in the
total and male samples. Individual SNP-based association analyses
revealed that seven SNPs within this region showed significant
associations with at least one smoking behavior in either or both
samples. Of these polymorphisms, rs951266 in CHRNA5 showed
the strongest association with SI (P=0.006) and SQ (P=0.001)
and rs11072768 in CHRNB4 with all the three smoking-related
phenotypes in the total (SI: P=0.015; SQ: P=0.028; SC:
P=0.018) and male (SI: P=0.001; SQ: P=0.016; SC:
P=0.010) samples. Furthermore, we found multiple haplotypes
between rs16969948 in CHRNA5 and rs6495316 or rs11638372 in
the intergenic region downstream from the 59 end of CHRNB4 that
were associated significantly with the three smoking-related
phenotypes in both the total and the male sample. Finally,
considering the fact that the protein products of these nAChR
subunit genes must assemble in order to form functional nAChRs,
we also performed gene-gene interaction analysis on all SNPs in
Table 4. Statistics estimates and P values for major haplotypes showing significant associations at the 0.05 level with at least one
smoking-related phenotype under the additive and dominant models in the male sample.
SNP Number SNP combinations
Haplo-
type Freq SI SQ SC
Esti-
mate P
Global
P
Esti-
mate P
Global
P
Esti-
mate P Global P
18-19-20 rs16969948-rs481134-rs951266 TCC 0.77 20.102
a 0.034
a 0.023
a 20.108
a 0.069
a 0.003
a 20.050
a 0.401
a 0.276
a
19-20-21 rs481134-rs951266-rs514743 CCT 0.82 20.173
a 0.020
a 0.037
a 20.186
a 0.005
a 0.001
a 20.011
a 0.869
a 0.529
a
20-21-22 rs951266-rs514743-rs6495308 CTG 0.74 20.114
a
20.265
d
0.015
a
0.025
d
0.008
a
0.137
d
20.124
a
20.307
d
0.032
a
0.031
d
0.003
a
0.158
d
20.077
a 0.186
a 0.303
a
21-22-23 rs514743-rs6495308-rs950776 TGA 0.74 20.118
a 0.011
a 0.071
a 20.134
a 0.019
a 0.060
a 20.082
a 0.155
a 0.411
a
22-23-24 rs6495308-rs950776-rs11072768 GAA 0.70 20.132
a 0.003
a 0.038
a 20.140
a 0.011
a 0.103
a 20.107
a 0.054
a 0.288
a
23-24-25 rs950776-rs11072768-rs7166158 AAT 0.57 20.101
a 0.018
a 0.024
a 20.116
a 0.029
a 0.112
a 20.072
a 0.180
a 0.161
a
ACT 0.12 0.168
a
0.238
d
0.009
a
0.001
d
0.024
a
0.013
d
0.173
a
0.214
d
0.026
a
0.014
d
0.112
a
0.117
d
0.162
a
0.210
d
0.043
a
0.019
d
0.161
a
0.154
d
24-25-26 rs11072768-rs7166158-rs8043123 ATC 0.38 20.094
a
20.141
d
0.032
a
0.029
d
0.010
a
0.073
d
20.047
a 0.393
a 0.208
a 20.050
a 0.359
a 0.009
a
CTC 0.15 0.157
a
0.149
d
0.010
a
0.035
d
0.010
a
0.073
d
0.159
a 0.031
a 0.208
a 0.159
a 0.036
a
26-27-29 rs8043123-rs4887077-rs11638372 CGG 0.53 20.229
d 0.022
d 0.035
d 20.134
d 0.128
d 0.021
d 0.122
d 0.158
d 0.369
d
(1) SI = smoking initiation; SQ = smoking quantity; SC = smoking cessation; (2) Significant associations at the 0.05 level before Bonferroni correction for multiple
testing are given in bold and those after Bonferroni correction for multiple testing are given in bold and underlined (corrected P value at a 0.05 significance level is
0.0125 under the assumption of a maximum of four major haplotypes for each SNP combination); (3) Superscripts indicate the genetic model used: a= additive; d=
dominant; and (4) For each sample, age, and area were used as covariates.
doi:10.1371/journal.pone.0012183.t004
Table 5. A significant interactive model for CHRNA5/A3/B4 cluster with SI in KARE male sample on the basis of the prediction
accuracy and the sign test P value.
No. of
Loci Best Model Prediction Accuracy Sign Test (P) CVC
5 LOC123688: rs7163730
CHRNA3: rs6495308
Inter-genic region: rs7166158, rs8043123, rs11072793
0.517 9 (0.011) 10/10
(1) SI = smoking initiation; (2) CVC = cross-validation consistency; and (3) In GMDR analysis, age and area were used as covariates.
doi:10.1371/journal.pone.0012183.t005
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five SNPs located in LOC123688, CHRNA3, and the intergenic
region at the 59 end of CHRNB4 that influences SI in the male
sample.
To assess ND, various scales have been developed, which
include the Diagnostic and Statistical Manual of Mental Disorders
(DSM)-IV criteria [4], Fagerstro ¨m Test for ND (FTND) [37], HSI
[38], the Nicotine Dependence Syndrome Scale (NDSS) [39], and
the Wisconsin Inventory of Smoking Dependence Motives
(WISDM-68) [40], to name a few. Among them, FTND is the
most widely used instrument, primarily because of its succinctness
and ease of administration [41]. The FTND score is commonly
treated as a continuous variable, and an FTND $4 is typically
defined as highly dependent [28,42]. CPD, the most commonly
used consumption measure [38], is both highly heritable [7] and
predictive of ND [24,38]. SQ is an ordinal variable based on CPD,
which provides a simple, quantified index of the amount of
cigarette consumption. It should be noted that SQ and FTND are
correlated but different psychometric measures of smoking
behavior. To date, associations of variants in the CHRNA5/A3/
B4 cluster with smoking have been detected for both SQ and
FTND phenotypes, but signals appear to be stronger for SQ than
for FTND (Figure 2), which is also true for linkage study on ND
based on a review of more than 20 independent studies [43].
There are several strengths of this study. First, although
significant associations of variants within the CHRNA5/A3/B4
cluster with smoking have been replicated in multiple independent
samples, almost all these studies were concentrated on smoking
dependence in samples of European origin [14,18,19,20,21,
22,23,24,25]. Very recently, relatively weak associations of some
variants of this gene cluster with ND were reported in two African
American samples [18,28]. Among the 76 SNPs investigated by
Saccone et al. [28], eight showed nominally significant association
with ND (P value =0.0147,0.0443), with rs16969968 in
CHRNA5 being the strongest, at a P value of 0.0147. Similarly,
in a prior study [18], we analyzed 22 SNPs within the gene cluster
and found that only rs8040868 in CHRNA3 showed a nominally
significant association with ND (P=0.017,0.039). However, none
of these associations survived correction for multiple testing in the
two African American samples [18,28]. Although there were two
studies investigating potential associations of variants in the gene
cluster with LC and smoking in Chinese [44] and Japanese [45]
subjects, no previous reports have examined the involvement of
variants of this cluster with smoking behavior in a strictly Asian
Figure 2. A summary of all reported SNPs that have been significantly associated with different smoking behaviors. Of these reported
studies mentioned in the figure, most were investigated on nicotine dependence except that the study authored by Keskitalo et al. [55] was on serum
cotinine level and that by Schlaepfer et al. [23] was on smoking initiation.
doi:10.1371/journal.pone.0012183.g002
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potential association of the CHRNA5/A3/B4 cluster with smoking
behaviors in an Asian population. By identifying risk alleles for
smoking and LC and comparing their frequencies in different
ethnic populations, it is easy to see that they are quite different,
which further underscores that different variants in this genomic
region contribute importantly to variations in disease risks among
different ethnic populations [12].
Second, most previous association studies of the CHRNA5/A3/
B4 cluster were focusing on ND or related measures
[14,15,19,24,25], although a few studies were focused on SI
[23,27] or SC [26,46,47]. Given the significant overlap of genetic
underpinnings among these three smoking-related phenotypes
[48,49], it is of great interest to investigate these phenotypes
systemically in one sample. This is especially true for the
CHRNA5/A3/B4 cluster, as it has been associated with ND in
several reports, especially in samples of European origin
[14,18,19,20,21,22,23,24,25]. However, association of the variants
of this cluster with SI and SC has not been well established. By
analyzing the three major smoking-related phenotypes together in
the Korean sample, we found significant associations of some
variants in this cluster with the three smoking-related phenotypes
at both the individual SNP and the haplotype levels.
Third, in this study, we not only performed association analyses
of this region with the three major smoking-related phenotypes at
the SNP and haplotype levels, as in most reported association
studies of the region with smoking, but also performed extensive
gene-gene interaction analysis exclusively in this region. This is
important in that: (1) all nAChR subunits except alpha 7 must
assemble under appropriate compositions in order to form
functional receptors; and (2) it is still undetermined whether other
uncharacterized genes of this region contribute to smoking-related
phenotypes [12]. Our gene-gene interaction results in the male
sample indicate clearly that some variants exist within the region
between rs7163730 in LOC123688 and rs11072793 in the
intergenic region downstream from the 59 end of CHRNB4 that
are contributing to SI through gene-gene interactions. This
appears consistent with findings from our recent study showing
an association of the region with ND in European American and
African American samples [18]. This has been the case for several
other genes also. For example, we recently detected a significant
interaction between variants of CHRNA4 and CHRNB2 in affecting
ND, such that CHRNB2 contributes significantly to the etiology of
ND together with CHRNA4 through gene-gene interaction [34].
Similarly, in another study, we found that GABAB1 contributes to
ND through its interaction with GABAB2, although no
significant association was observed for GABAB1 with ND directly
[35].
There exist several limitations to this study. First, we did not
consider Bonferroni correction for all possible multiple testing,
primarily because we consider this study a replication of a positive
association of this cluster with ND in an independent sample. A
similar approach has been adopted by other researchers [25]. If we
include correction for multiple testing, most detected associations
of variants within this cluster with SI, SQ and SC at both the
individual SNP and haplotype levels become non-significant, with
the exceptions that rs951266 in CHRNA5 remained significant for
SQ and rs11072768 in CHRNB4 for SI in the male sample (see
Table 3). Similarly, we found that associations of four major
haplotypes with SI and two major ones with SQ remained
significant after Bonferroni correction for multiple testing of major
haplotypes (Table 4). However, no significant associations of any
SNPs or haplotypes with SC remained after Bonferroni correction
for multiple testing. Also, we did not correct for our testing of two
genetic models and three phenotypes, as they are highly related,
which violates the assumption of independence for Bonferroni
correction. Because of the aforementioned concerns, to some
extent, we consider this study explorative, and more replication in
Korean or other Asian samples is greatly needed. Second,
although we defined the three smoking-related phenotypes on
the basis of all the related information collected from each smoker,
we are not fully convinced this is the best sample for investigation
of this gene cluster and smoking behaviors, as this work was not
designed originally as a genetic study on smoking, and the
information collected from each smoker is limited. For example,
SQ was assessed by CPD instead of ND determined by the FTND
or DSM-IV criteria commonly used in other studies. Also, there
was no SQ information (i.e., a 5-category ordinal trait based on
CPD) for light or occasional smokers, although we do know they
smoked only when they were in specific social circumstances such
as during a party or gathering with their friends. Further, the SC
status was based on individual self-reports, which were not
biochemically verified, and this might lead to potential bias in
phenotyping. Nevertheless, we do not feel this bias would greatly
affect our results, as the definitions used in the current study have
been used in other studies of this type as well [27,43]. This is
especially true for SQ, as it produces significantly more positive
findings than any other smoking measures for ND in both linkage
and association analyses [43]. Third, we investigated the
association of this cluster with three smoking-related phenotypes
only in the Korean total and male samples. We did not perform a
similar analysis of the female sample because of the small sample
size attributable to the small percentage of female smokers (3%),
which is the case for many other Asian countries such as China
(,4% of Chinese women aged 15 years or older are smokers [50]).
Thus, we could not determine whether this gene cluster has any
significant impact on smoking behaviors in Korean women.
Finally, the number of informative SNPs genotyped within
this region was limited. To have a better coverage for these
samples, more SNPs with a high density are greatly needed for
further analysis of this cluster in relation to smoking-related
phenotypes.
As shown in Table S1, the allele frequencies of an array of
genetic variants (e.g., rs7168796, rs16969922, and rs1979906, to
name a few) located in CHRNA5/A3/B4 differ dramatically across
ethnic and geographical populations (i.e., the Caucasian [CEU],
African [YRI], and Asian [CHB, JPT, and Korean] samples).
Therefore, this study provides an essential basis for genetic
association analysis by comparing different frequencies of SNPs of
this region between smoking and non-smoking populations to
examine whether such associations are consistent in different
ethnicities. Indeed, different genotype frequencies have been
compared in smoking and non-smoking populations in different
ethnic groups for several polymorphisms of CYP2A6 [51] as well
as a 44-bp insertion/deletion polymorphism of the serotonin
transporter (5-HTT) gene [52], and such studies may shed new
light on what molecular variants have diverging effects, and what
molecular variants have converging effects in populations of
different ancestries. This approach is termed ‘‘cross-population
contrast mapping’’ based on the hypothesis that important
biological mechanisms underlying a disease of interest are shared
by various human populations, although differences in allele
frequencies at risk loci could result in different prevalences in
different populations [53]. Because smoking is a significant risk
factor for LC, and the association of CHRNA5/A3/B4 with
smoking or LC risk had been reported in many other populations,
the present work should contribute to establishing that different
polymorphic CHRNA5/A3/B4 patterns associate with the physi-
nAChR Variants and Smoking
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To compare the association signals detected by this study with
those detected in other populations from previous studies, we have
summarized both individual SNP and haplotype results in
Figures 2 and 3, respectively. To our knowledge, approximately
25 SNPs in this region are reported to be associated with smoking-
related and LC phenotypes. Among the 7 SNPs found to be
nominally associated with SI, SQ, and SC, rs6495308 in CHRNA3
was also found associated with CPD in two European American
samples [24]. All the remaining 6 SNPs (1 in CHRNA5,1i n
CHRNB4, and 4 in the intergenic regions) were unique to this
Korean sample. It would be of great interest to individually
genotype additional SNPs in this region in the sample, especially
rs1051730 and rs16969968, which showed unequivocally signif-
icant association signals with SQ or CPD in several previous
studies [15,54,55]. Recently, Le Marchand et al. [56] used urinary
biomarkers to test whether rs1051730 and rs16969968 are
associated with a higher level of nicotine and exposure to
tobacco-specific carcinogenic substances per cigarette dose in a
Hawaii study of 583 men and women of European, Japanese, or
Native Hawaiian ancestry who were long-term smokers of more
than 10 cigarettes per day. Although the T of rs1051730 and A of
rs16969968 alleles were less common in Japanese Americans (3%)
and Native Hawaiians (,19%) than in European Americans
(34%), those investigators found that carriers of T of rs1051730 or
A of rs16969968 extract a greater amount of nicotine (P=0.004
and 0.003, respectively) and those A carriers of the rs16969968
had a higher internal dose of total 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanol (P=0.03) per cigarette than non-carriers. In
another study with a sample size of ,17,300 subjects from five LC
studies and four upper aerodigestive tract cancer studies, Lips et al.
[57] revealed no association between rs16966968 and SI or SC,
age at SI, or age at SC. However, when cancer cases and controls
were combined (after adjustment for case/control status), the
adjusted mean difference between the two homozygote genotypes
was 1.2 CPD (P,0.0001). Moreover, the rs16969968 genotype
was associated with LC in both former (P,0.0001) and current
(P,0.0001) smokers, and a marginally significant trend was
observed in never smokers (P=0.07).
At the haplotype level, in the three long-term EA smoker
cohorts recruited in Utah, Wisconsin, and by the NHLBI Lung
Health Study, Weiss et al. [19] found that a 5-SNP haplotype HA
(CCAGA) formed by rs680244-rs569207-rs16969968-rs578776-
rs1051730 (denoted EA_H1), had a risk effect on high FTND
score (.6) compared with low FTND score (,4) (OR=1.50, 95%
CI: 1.21, 1.86, P=1.3610
24), and the 5-SNP haplotype HC
(CTGAG) formed by the same SNPs as in HA had a protective
Figure 3. A summary of all reported haplotypes that have been significantly associated with different smoking behaviors in the AA,
EA and Korean samples.
doi:10.1371/journal.pone.0012183.g003
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23). Such findings corroborated for ND assessed by
Primary Dependence Motives (PDM) score [46]. Further, our
previous study in the Mid-South Tobacco Family (MSTF) cohort
revealed 3 additional haplotypes in EAs [18], formed by
rs6495308-rs3743075-rs8040868 (EA_H2), rs3743075-rs8040868-
rs6495309 (EA_H3), and rs17408276-rs16969968-rs615470
(EA_H4), that were associated with smoking-related phenotypes.
In comparison with EA_H1, although EA_H4 was physically
encompassed by EA_H1, and they share 1 SNP (i.e., rs16969968),
EA_H2 and EA_H3, which have 2 overlapping SNPs (i.e.,
rs3743075 and rs8040868), were physically separate from EA_H1.
Also in the MSTF cohort, we detected two AA haplotypes formed
by rs1317286-rs12914385-rs2869546 (AA_H1) and rs2869546-
rs6495308-rs3743075 (AA_H2), which share 1 SNP (i.e.,
rs2869546) (Figure 3). Comparing the detected haplotypes in
AAs and EAs, AA_H1 does not physically overlap with any of the
4 EA haplotypes, and AA_H2 shares 2 SNPs (i.e., rs6495308 and
rs3743075) with EA_H2, as well as 1 SNP (i.e., rs3743075) with
EA_H3. Although the overall physical region spanned by the 9
overlapping Korean haplotypes identified in this study from
rs16969948 to rs6495316 does encompass all 4 EA haplotypes (i.e.,
EA_H1, EA_H2, EA_H3, and EA_H4) as well as both AA
haplotypes (i.e., AA_H1 and AA_H2), these 9 Korean haplotypes
do not share any SNPs with EA_H1 EA_H3, EA_H4 or AA_H1.
Nevertheless, 3 Korean haplotypes (Korean_H3, Korean_H4, and
Korean_H5) do share an SNP (i.e., rs6495308) with EA_H2 and
AA_H2. Overall, the Korean haplotypes provide some support for
the importance of the EA and AA haplotypes previously associated
with smoking-related phenotypes However, because the SNP
compositions differ across EA, AA and Korean haplotypes, the
haplotype association signals are not directly comparable. To get a
clearer picture of cross-population haplotypic effects, it is essential
to examine the effects of haplotypes with the same SNP
combinations on smoking behavior across different ethnic
populations given that haplotype frequencies differ so dramatically
in populations of different ancestries.
The problem of multiple hypothesis testing in biomedical studies
is an important yet complex issue that needs to be considered
carefully [58]. For complex traits such as smoking behavior,
variants in genes of multiple biological pathways are likely to be
involved in producing the phenotype through their mutual
interactions and interactions with environmental factors. There-
fore, genetic effects of common variants for smoking behavior are
often weak secondary to genetic heterogeneity, variable expres-
sivity, and low penetrance; and exactly how to correct for multiple
testing remains a debatable and profound topic. For example, for
gene-based studies such as this study focusing on the CHRNA5/
A3/B4 cluster, Neale and Sham [59] have emphasized the
importance of replication rather than the sole interest of detecting
association signals with very low P values, and the authors have
challenged the need for correcting for multiple testing in this
specific scenario. Conversely, from a statistical viewpoint, when a
data set is tested in multiple angles, the threshold for statistical
significance should be adjusted to reduce the inflated type I error.
To correct for multiple testing, as suggested by Feise [60], a
prudently chosen balance needs to be reached for a study’s
statistical significance in consideration of multiple factors such as
the magnitude of the genetic effect, biological function(s) of the
marker(s) of interest, the study’s quality, as well as the collective
supportive evidence of the genetic locus from other independent
studies [60]. Specifically, in this study, we applied the Bonferroni
correction procedure for the number of SNPs analyzed within
each sample for a given phenotype, but we did not correct for the
number of smoking-related phenotypes (i.e., SI, SQ, and SC), the
number of genetic models employed (i.e., recessive, additive, and
dominant), or the number of study samples (i.e., total and male
sample). The rationales underlying our decisions are that the
smoking-related phenotypes are highly inter-related, the male
smokers constitute the predominant fraction of all smokers in the
total sample, and the three genetic models cannot be treated as
totally independent. Therefore, given that the variants in
CHRNA5/A3/B4 have been associated with smoking behavior in
various independent samples of European origin, the correction
employed was a balanced decision between the application of a
relatively stringent Bonferroni correction and a precaution in
guarding against an over-correction that could result in unintend-
ed losses of power and valuable information [61,62].
In sum, this is the first genetic study aimed at investigating any
association of the variants of the CHRNA5/A3/B4 cluster with SI,
SQ, and SC in Korean smokers. Despite the caveats regarding
correction for multiple testing, our replication of prior reported
significant associations of CHRNA5/A3/B4, combined with the
convergent biological data implicating the functional roles of
nAChR subunit genes residing in this cluster in addiction,
strengthens the notion that the multiple nominally significant
association signals we detected at both the SNP and haplotype
levels in the Korean sample are true positives. Moreover, our study
is the first to show that the nominally significant association signals
have extended beyond the 59 end of CHRNB4 to the flanking
intergenic region. Further, we found that the associations of this
cluster region with SI and SQ phenotypes appeared to be stronger
than those with the SC phenotype in Koreans smokers. Finally, we
provided evidence for nominally significant interactions among
variants studied in affecting SI in the male sample. Although these
findings are novel and encouraging, they do need to be confirmed
in larger, independent studies of subjects with Asian ancestry.
Materials and Methods
Ethics statement
Informed written consent was obtained in advance from all
participants using a form approved by all participating Institu-
tional Review Boards. The study likewise was approved by the
Institutional Review Boards of the National Institute of Health of
Korea, Seoul National University, and the University of Virginia
and was in accordance with the principles of the Helsinki
Declaration II.
Subjects and genotyping
The relevant information for the subjects in the current study
has been reported [63]. Briefly, samples from the 10,038
participants in the Korea Association Resource (KARE) Project
were obtained in two recruiting areas, Ansung and Ansan, in
South Korea. Participant ages ranged from 40 to 69 years.
Genomic DNA was available for 10,004 participants and was
genotyped with the Affymetrix Genome-Wide Human SNP Array
5.0. Genotypes were called with Bayesian Robust Linear Modeling
using the Mahalanobis Distance (BRLMM) algorithm. Those
samples with low call rates (N=401), contamination (N=11), sex
inconsistencies (N=41), cryptic relatedness (N=608), or serious
concomitant illness (N=101) were removed. After all the samples
had been filtered with this standard quality control procedure [63],
8,842 individual samples remained for the current study (4,183
males and 4,659 females).
Although we had genotyping data available for other SNPs in
these samples, in this study, we focused only on the CHRNA5/A3/
B4 region of chromosome 15, as this region has received much
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According to the genomic locations, 36 SNPs were selected. Of
them, 32 met our inclusion criteria for this study with a satisfying
Hardy-Weinberg equilibrium P value .10
26, MAF .0.01, and
genotype call rates .95%. The 36 SNPs are described in Table 1.
Definition of smoking-related phenotypes
On the basis of the survey questionnaire, from which
information on smoking status (i.e., never smoker, former smoker,
occasional or light smoker, and habitual smoker) and CPD for the
habitual smokers were drawn, three smoking-related phenotypes
were defined: SI, SQ, and SC. Regarding SI, the first measure
(called SI-1) was defined as a binary trait comparing ‘‘never
smoked’’ and ‘‘having regular smoking experiences,’’ and the
second measure (called SI-2) was defined as an ordinal trait with
four categories: never, former, light, and habitual. Because the
association results for these two SI measures appear to be similar,
in this communication, we show them together under the SI
phenotype. The SQ phenotype was defined as an ordinal trait with
five categories (1–5) according to CPD: non-smoking, ,10 CPD,
11 to 20 CPD, 21 to 30 CPD, and .31 CPD. Such assessment of
SQ not only has been commonly used in the literature but also is
the most productive in terms of positive findings [43]. Finally, the
SC phenotype was defined as a binary trait comparing ‘‘former
smoking’’ and ‘‘current smoking.’’
Association analysis
Statistical analysis was performed using PLINK [29] and R
software. For the binary phenotypes, SI-1 and SC, the association
tests were performed using logistic regression analysis, with age, sex,
and geographic area of recruitment as covariates under the additive
and dominant models. The cumulative logit model was fit to the
ordinal phenotypes SI-2 and SQ [64]. LD analysis was performed
using Haploview software [30] with the option of determining
haplotype blocks according to the definitions proposed by Gabriel et
al. [31]. Haplotypes were reconstructed using SNPs within the
genomic region containing the CHRNA5/A3/B4 cluster with sliding
window sizes of 3 to 5. Haplotype-based association analysis was
carried out with the haplo.stats R statistics package [33] under
additive and dominant models, adjusting for age, sex, and
geographic area. As we consider this study a replication of reported
significant association of variants of this gene cluster with smoking
behavior in an independent sample [14,15,16,17,24], we did not
correct for multiple comparisons for the two genetic models and
three smoking-related phenotypes, primarily because they are
related, when we interpreted our findings following the concept and
approachused byotherresearchers [25]. However, wedo recognize
a potential limitation of this approach, which is addressed in the
Discussion section herein.
Interaction analysis of variants in the CHRNA5/A3/B4
cluster
For the interaction analysis of variants in the CHRNA5/A3/B4
region, both logistic regression and generalized multifactor
dimensionality reduction (GMDR) analyses [36] were performed
for binary traits (SI-1 and SC), whereas the cumulative logit model
was applied to the ordinal phenotypes (SI-2 and SQ). The logistic
regression model and cumulative logit model included the main
effects of SNPs, interaction effects among the SNPs, as well as
adjusting covariates. The log-likelihood ratio test was performed
for testing the joint significance of SNP main and interaction
effects. The GMDR analysis was carried out only for the binary
traits, as GMDR analysis is not applicable to ordinal traits. Age,
sex, and recruiting area were considered as adjusting covariates for
all interaction analyses. The best SNP combination for all two- to
six-locus models was selected via the prediction rate.
Supporting Information
Table S1 Positions, nucleotide variations, and allele frequencies
for SNPs on chromosome 15.
Found at: doi:10.1371/journal.pone.0012183.s001 (0.09 MB
DOC)
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